Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
about
Therapy-related myeloid neoplasms - what have we learned so far?Therapy-related myeloid neoplasms: pathobiology and clinical characteristicsTherapy-related myelodysplastic syndrome.A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
P2860
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment of therapy-related m ...... opoietic stem cell transplant.
@ast
Treatment of therapy-related m ...... opoietic stem cell transplant.
@en
type
label
Treatment of therapy-related m ...... opoietic stem cell transplant.
@ast
Treatment of therapy-related m ...... opoietic stem cell transplant.
@en
prefLabel
Treatment of therapy-related m ...... opoietic stem cell transplant.
@ast
Treatment of therapy-related m ...... opoietic stem cell transplant.
@en
P2093
P2860
P1433
P1476
Treatment of therapy-related m ...... opoietic stem cell transplant.
@en
P2093
Andrew Artz
Christopher K Daugherty
Elizabeth S Rich
Howard Weiner
Lucy A Godley
Margaret Green
Michelle M Le Beau
Olatoyosi Odenike
Uchenna O Njiaju
P2860
P304
P356
10.3109/10428191003763468
P577
2010-06-01T00:00:00Z